AMN Healthcare Services, Inc.

NYSE:AMN

Medical - Care Facilities

Healthcare
$37.60 -3.98%

-$1.29 today

Market cap
$1.45B
Beta
0.44
P/E (TTM)
-37.3
EPS (TTM)
-$0.83
52W Low $14.87High $33.13

Volume 0.55M

Average 1.02M

AMN EBITDA Margin

EBITDA as a percentage of revenue.

AMN Healthcare Services, Inc.NYSE: AMN

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 11.1%

EBITDA Margin was 11.1% in Q1 FY2026, up 3.5 pp from a year earlier. On a trailing-twelve-month basis it was 5.9%, up 4.5 pp year over year. Over 3 fiscal years it narrowed by 11.3 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 11.7% for the fiscal year ending Dec 2026, up from 3.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
11.1%+5.0 pp QoQ
Last fiscal yearDec 2025
3.7%+1.3 pp YoY
LTMMar 2026
5.9%+4.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.5 pp+20.8 pp+17.3 pp
1 year+1.3 pp+8.0 pp+6.7 pp
3 years-11.3 pp+4.4 pp+15.7 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
3.7%
Year-over-year change
+1.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How AMN compares with its peers on the latest reported figures

  • AMN's LTM Mar 2026 EBITDA Margin of 5.9% is the 3rd highest of the 9 companies compared; the peer median is -21.6%.
  • Its year-over-year change of +4.5 pp is the 3rd highest of 9, against a peer median of -0.5 pp.
  • Over three fiscal years its change of -11.3 pp compares with a peer median of -0.0 pp.
AMN Competitors Peer median
EBITDA Margin for AMN and competitors
Company Period LTM level YoY 3-year change
NUTXNutex Health, Inc.LTM Mar 202633.2% -1.1 pp+212.5 pp
HSTMHealthStream, Inc.LTM Mar 202622.4% +0.1 pp+1.9 pp
AMNAMN Healthcare Services, Inc.LTM Mar 20265.9% +4.5 pp-11.3 pp
AIRSAirSculpt Technologies, Inc.LTM Mar 20262.8% +4.1 pp-1.9 pp
EVHEvolent Health, Inc.LTM Mar 2026-16.7% -18.0 pp-22.5 pp
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026-26.6% +89.9 pp-148.5 pp
MYGNMyriad Genetics, Inc.LTM Mar 2026-40.3% -32.6 pp-27.6 pp
BFLYButterfly Network, Inc.LTM Mar 2026-64.8% -2.6 pp+152.7 pp
DNAGinkgo Bioworks Holdings, Inc.LTM Mar 2026-149.2% +14.0 pp+281.5 pp
REPLReplimune Group, Inc.FY2025— ——
CMPSCOMPASS Pathways plcFY2025— ——
Peer median (excluding AMN) -21.6%-0.5 pp-0.0 pp

Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.98B5.24B3.79B2.98B2.73B
Cost of Revenue2.67B3.53B2.54B2.06B1.96B
Gross Profit1.31B1.72B1.25B919.38M774.06M
Gross Margin32.9%32.7%33.0%30.8%28.3%
Research & Development00000
Selling, General & Admin730.45M936.58M756.24M632.49M593.02M
Operating Expenses831.6M1.07B911.15M1.02B740.89M
Depreciation & Amortization103.7M137.11M160.93M173.78M156.6M
EBITDA581.7M784.21M499.36M71.11M101.13M
EBITDA Margin14.6%15.0%13.2%2.4%3.7%
Operating Income478M647.1M338.43M(102.67M)33.17M
Operating Margin12.0%12.3%8.9%-3.4%1.2%
Interest Income00000
Interest Expense34.08M40.4M54.14M69.9M45.59M
Other Income / Expenses(34.08M)(40.4M)(54.14M)(69.9M)(134.23M)
Income Before Tax443.92M606.7M284.29M(172.57M)(101.06M)
Pre-Tax Margin11.1%11.6%7.5%-5.8%-3.7%
Income Tax Expense116.53M162.65M73.61M(25.6M)(5.36M)
Net Income327.39M444.05M210.68M(146.98M)(95.7M)
Net Margin8.2%8.5%5.6%-4.9%-3.5%
EPS (Basic)6.879.965.38(3.85)(2.48)
EPS (Diluted)6.819.905.36(3.85)(2.48)
Weighted Avg Shares47.69M44.59M39.17M38.19M38.52M
Weighted Avg Shares (Diluted)48.05M44.87M39.34M38.19M38.52M

AMN Healthcare Services, Inc.

NYSE:AMN

Intrinsic Alpha fair value

Locked

Current Price

$37.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.